[Therapy of plasmacytoma]

Epirubicin and ifosfamide in metastatic breast cancer.

Seminars in oncology·1996

Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society.

Onkologie·1991

Phase II study of vinorelbine by oral route (in a hard gelatine capsule) for metastatic breast cancer patients. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.

Onkologie·1991

Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.

Onkologie·1990

Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.

Onkologie·1990

Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.

Onkologie·1990

[Nicotine Harms the Heart: No Safe Product, No Excuse for Political Inaction].

Deutsche medizinische Wochenschrift (1946)·2026

[Mind the bat: Rare Infection as Lung Cancer Mimic - a Case Report].

Deutsche medizinische Wochenschrift (1946)·2026

[Multimorbidity and frailty as geriatric syndromes - Similarities and differences].

Deutsche medizinische Wochenschrift (1946)·2026

[Multimorbidity in Geriatric Oncology].

Deutsche medizinische Wochenschrift (1946)·2026

[Multimorbidity in neurodegenerative diseases].

Deutsche medizinische Wochenschrift (1946)·2026

[Chronic obstructive pulmonary disease (COPD), advanced age, and comorbidities].

Deutsche medizinische Wochenschrift (1946)·2026

Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.

The journal of vascular access·2026

Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.

Indian journal of pharmacology·2026

Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.

Journal of immunotherapy (Hagerstown, Md. : 1997)·2026

Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.

Expert review of pharmacoeconomics & outcomes research·2026

Improving Cognitive Impairment in Cancer Patients With an Online Course in Mindfulness-Based Stress Reduction-A Randomized Controlled Trial.

Psycho-oncology·2026

Cytokine Release Syndrome Induced by Neoadjuvant Pembrolizumab in Early Triple-Negative Breast Cancer: A Case Report with Implications for Early Diagnosis and Management.

Case reports in oncology·2026

Related Experiment Videos

[Therapy of plasmacytoma]

Related Concept Videos

Epirubicin and ifosfamide in metastatic breast cancer.

Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society.

Phase II study of vinorelbine by oral route (in a hard gelatine capsule) for metastatic breast cancer patients. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.

Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.

Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.

Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.

[Nicotine Harms the Heart: No Safe Product, No Excuse for Political Inaction].

[Mind the bat: Rare Infection as Lung Cancer Mimic - a Case Report].

[Multimorbidity and frailty as geriatric syndromes - Similarities and differences].

[Multimorbidity in Geriatric Oncology].

[Multimorbidity in neurodegenerative diseases].

[Chronic obstructive pulmonary disease (COPD), advanced age, and comorbidities].

Comparative safety of PICC-ports and chest ports in oncology: A monocentric retrospective cohort study.

Combinatorial effects of curcumin, morin, and phyllanthin in MDA-MB-231 and MCF-7 breast cancer cell lines.

Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.

Cost-effectiveness analysis of liposomal Irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.

Improving Cognitive Impairment in Cancer Patients With an Online Course in Mindfulness-Based Stress Reduction-A Randomized Controlled Trial.

Cytokine Release Syndrome Induced by Neoadjuvant Pembrolizumab in Early Triple-Negative Breast Cancer: A Case Report with Implications for Early Diagnosis and Management.

Related Experiment Videos

[Therapy of plasmacytoma]

Related Concept Videos

Related Articles